Genesco Financial Statements (GCO)
|
|
|
|
Report date
|
|
|
22.03.2023 |
31.01.2024 |
27.03.2024 |
26.03.2025 |
25.03.2026 |
|
25.03.2026 |
|
Currency
|
|
|
USD |
USD |
USD |
USD |
USD |
|
USD |
|
Financial report URL
|
|
|
|
|
|
|
|
|
|
|
|
Revenue, bln rub |
? |
|
2 385 |
2 325 |
2 325 |
2 325 |
2 436 |
|
2 436 |
|
Operating Income, bln rub |
|
|
94.1 |
16.8 |
16.8 |
17.2 |
25.4 |
|
25.4 |
|
EBITDA, bln rub |
? |
|
136.1 |
23.6 |
35.8 |
66.7 |
70.7 |
|
70.7 |
|
Net profit, bln rub |
? |
|
71.9 |
-16.8 |
-16.8 |
-18.9 |
13.3 |
|
13.3 |
|
|
OCF, bln rub |
? |
|
-164.9 |
|
94.8 |
87.9 |
145.8 |
|
145.8 |
|
CAPEX, bln rub |
? |
|
59.9 |
|
60.3 |
41.1 |
62.1 |
|
104.4 |
|
FCF, bln rub |
? |
|
-224.8 |
|
34.5 |
46.8 |
83.7 |
|
145.8 |
|
Dividend payout, bln rub
|
|
|
0.000 |
|
0.000 |
0.000 |
0.000 |
|
0.000 |
|
|
Ordinary share dividend yield, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
|
|
0.00% |
|
Dividend payout ratio, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0 |
|
|
OPEX, bln rub |
|
|
1 042 |
1 082 |
1 082 |
1 080 |
1 101 |
|
1 101 |
|
Cost of production, bln rub |
|
|
1 249 |
1 226 |
1 226 |
1 228 |
1 309 |
|
1 309 |
|
R&D, bln rub |
|
|
0.000 |
0.000 |
0.000 |
0.000 |
0.000 |
|
0.000 |
|
Interest expenses, bln rub |
|
|
3.22 |
7.78 |
8.18 |
4.95 |
4.80 |
|
4.80 |
|
|
Assets, bln rub |
|
|
1 456 |
1 330 |
1 330 |
1 336 |
1 393 |
|
1 393 |
|
Net Assets, bln rub |
? |
|
607.0 |
571.2 |
571.2 |
547.0 |
567.0 |
|
567.0 |
|
Debt, bln rub |
|
|
580.4 |
522.9 |
522.9 |
485.1 |
521.4 |
|
521.4 |
|
Cash, bln rub |
|
|
48.0 |
35.2 |
35.2 |
34.0 |
105.4 |
|
105.4 |
|
Net debt, bln rub |
|
|
532.4 |
487.8 |
487.8 |
451.1 |
416.0 |
|
416.0 |
|
|
Ordinary share price, rub |
|
|
48.3 |
27.8 |
27.8 |
41.7 |
|
|
27.0 |
|
Number of ordinary shares, mln |
|
|
12.5 |
11.2 |
11.2 |
10.8 |
10.4 |
|
10.3 |
|
|
Market cap, bln rub |
|
|
602 |
312 |
312 |
451 |
0 |
|
279 |
|
EV, bln rub |
? |
|
1 134 |
800 |
800 |
902 |
416 |
|
695 |
|
Book value, bln rub |
|
|
541 |
571 |
534 |
512 |
530 |
|
530 |
|
|
EPS, rub |
? |
|
5.77 |
-1.50 |
-1.50 |
-1.74 |
1.28 |
|
1.28 |
|
FCF/share, rub |
|
|
-18.0 |
0.00 |
3.07 |
4.31 |
8.08 |
|
14.1 |
|
BV/share, rub |
|
|
43.5 |
50.8 |
47.5 |
47.3 |
51.1 |
|
51.2 |
|
|
EBITDA margin, % |
? |
|
5.71% |
1.01% |
1.54% |
2.87% |
2.90% |
|
2.90% |
|
Net margin, % |
? |
|
3.02% |
-0.72% |
-0.72% |
-0.81% |
0.54% |
|
0.54% |
|
FCF yield, % |
? |
|
-37.4% |
0.00% |
11.0% |
10.4% |
|
|
52.3% |
|
ROE, % |
? |
|
11.8% |
-2.95% |
-2.95% |
-3.45% |
2.34% |
|
2.34% |
|
ROA, % |
? |
|
4.94% |
-1.27% |
-1.27% |
-1.41% |
0.95% |
|
0.95% |
|
|
P/E |
? |
|
8.36 |
-18.6 |
-18.6 |
-23.9 |
0.00 |
|
21.0 |
|
P/FCF |
|
|
-2.68 |
|
9.05 |
9.65 |
0.00 |
|
1.91 |
|
P/S |
? |
|
0.25 |
0.13 |
0.13 |
0.19 |
0.00 |
|
0.11 |
|
P/BV |
? |
|
1.11 |
0.55 |
0.58 |
0.88 |
0.00 |
|
0.53 |
|
EV/EBITDA |
? |
|
8.33 |
33.9 |
22.3 |
13.5 |
5.88 |
|
9.83 |
|
Debt/EBITDA |
|
|
3.91 |
20.7 |
13.6 |
6.76 |
5.88 |
|
5.88 |
|
|
R&D/CAPEX, % |
|
|
0.00% |
|
0.00% |
0.00% |
0.00% |
|
0 |
|
|
CAPEX/Revenue, % |
|
|
2.51% |
0.00% |
2.59% |
1.77% |
2.55% |
|
4.28% |
|
| Genesco shareholders |
